SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2007-03-13
Filing Date Changed: 2007-03-16
Documents: 7
SEC Accession No.
0001193125-07-056783
Filing date: 2007-03-16
Accepted: 2007-03-16 13:02:46
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K d8k.htm 21622 FORM 8-K
2 EX-4.1 dex41.htm 77454 FORM OF GLOBAL NOTE
3 EX-4.2 dex42.htm 598232 INDENTURE
4 EX-4.3 dex43.htm 106097 REGISTRATION RIGHTS AGREEMENT
5 EX-10.1 dex101.htm 162124 PURCHASE AGREEMENT
6 EX-10.2 dex102.htm 60630 AMENDMENT NO. 5 TO THE CREDIT AGREEMENT
7 EX-99.1 dex991.htm 3384 PRESS RELEASE
0001193125-07-056783.txt 1031950 Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 07699023
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

  Assistant Director 1
Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674
 Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 07699022
SIC: 8060 Services-Hospitals

  Assistant Director 1
Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766
 Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060